Clinical Trial Update: REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women [Phase 3]

View source ↗

Summary

Phase 3 clinical trial RECHARGE is evaluating revascularization choices among women with coronary artery disease; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Coronary Artery Disease | Phase 3 | Status: RECRUITING